Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022

BUY
$1.09 - $1.66 $2,507 - $3,818
2,300 Added 11.27%
22,700 $32,000
Q3 2021

Nov 16, 2021

BUY
$1.13 - $1.65 $2,373 - $3,465
2,100 Added 11.48%
20,400 $23,000
Q2 2021

Aug 16, 2021

BUY
$1.51 - $2.07 $27,633 - $37,881
18,300 New
18,300 $29,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.86B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.